CD81 anticorps

N° du produit ABIN7865605

Cet anticorps anti-CD81 Monoclonal Souris (Clone 1-3-3-22) (ABIN7865605) détecte spécifiquement CD81 dans FACS, WB, IHC, IF et ICC. L’anticorps est réactif avec des échantillons de Humain.

Aperçu rapide pour CD81 anticorps (ABIN7865605)

Antigène: CD81

Reactivité: Humain

Hôte: Souris

Clonalité: Monoclonal

Conjugué: Cet anticorp CD81 est non-conjugé

Application: Flow Cytometry (FACS), Western Blotting (WB), Immunohistochemistry (IHC), Immunofluorescence (IF), Immunocytochemistry (ICC)

Clone: 1-3-3-22

Détail du produit anti-CD81 anticorps

Fonction: anti-CD81 mouse monoclonal, 1.3.3.22, purified

Purification: affinity chromatography

Immunogène: B-cell line derived from a Burkitt lymphoma

Isotype: IgG1 kappa

Information d'application

Indications d'application:

ICC/IF_dilution: 1:50-1:100 (1-2 μg/mL)

FACS_dilution: 1-2 μg/million cells in 0,1 ml

IHC-paraffin_dilution: 1:50-1:100 (1-2 μg/mL, microwave treatment in 10 mM citrate buffer pH 6.0 recommended)

WB_dilution: 1:50-1:100 (1-2 μg/mL)

IHC-frozen_dilution: 1:50-1:100 (1-2 μg/mL)

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 100 μg/mL

Buffer: PBS with 0.02 % sodium azide

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: 4 °C

Stockage commentaire: store at 2 - 8 °C

Détails sur CD81

Antigène: CD81

Autre désignation: CD81

Sujet: 1.3.3.22 Reacts with human CD81 (TAPA-1), a 24 kDa member of the TM4 superfamily of proteins with four transmembrane domains. MAbs to CD81 have been shown to have anti-proliferative effects on different lymphoid cell lines, particularly those derived from large cell lymphomas. CD81 can associate with CD37 and/or CD53, or on the surface of B-cells with CD19, CD21 and/or MHC class II molecules. 1.3.3.22 Was clustered at the VIth WLDA. Positive control: Ramos cells, human tonsil.

Pathways: Inositol Metabolic Process, Hepatitis C